Sit Investment Associates’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
72,305
+3,800
+6% +$481K 0.19% 133
2026
Q1
$7.38M Buy
68,505
+1,535
+2% +$173K 0.15% 161
2025
Q4
$7.56M Sell
66,970
-1,660
-2% -$159K 0.15% 164
2025
Q3
$5.6M Buy
68,630
+23,340
+52% +$2.14M 0.11% 192
2025
Q2
$4.68M Buy
45,290
+27,650
+157% +$2.59M 0.1% 202
2025
Q1
$1.74M Buy
17,640
+825
+5% +$110K 0.04% 322
2024
Q4
$2.52M Hold
16,815
0.06% 294
2024
Q3
$2.19M Buy
16,815
+7,900
+89% +$983K 0.05% 300
2024
Q2
$1.05M Buy
+8,915
New +$946K 0.02% 359

Other funds holding GKOS

Sit Investment Associates's GKOS Position: Q2 2026 in Review

Sit Investment Associates increased its Glaukos (GKOS) stake by 5.5% in Q2 2026, buying an estimated $481K and bringing the position to 72,305 shares worth $10.1M. The position accounts for 0.19% of the portfolio, ranked #133.

Sit Investment Associates first reported a position in GKOS in Q2 2024 and has held it in 9 quarters since. 366 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Sit Investment Associates held 72,305 shares of Glaukos worth $10.1M as of Q2 2026.
  • Sit Investment Associates bought 3,800 Glaukos shares in Q2 2026, an estimated $481K.
  • Glaukos made up 0.19% of Sit Investment Associates's portfolio in Q2 2026, its #133 holding.
  • Sit Investment Associates first reported a position in Glaukos in Q2 2024 and has held it in 9 quarters since.
  • 366 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.